Compare Johnson & Johnson (JNJ) vs NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) (NWG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) trades at $17.13 (market cap $66.98B). The key difference: Johnson & Johnson is far larger — about 9.2× NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)'s market cap, and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) pays the higher dividend (5.5%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares) for 1 Days on average.
| JNJ | NWG | |
|---|---|---|
Market Cap | $618.09B | $66.98B |
Volume | 6,050,983 | 5,259,060 |
Sector | Health | Financials |
52-Week High | $278.43 | $19.42 |
52-Week Low | $186.00 | $13.89 |
Typical Hold Time | 129 Days | 1 Days |
Enterprise Value | $646.37B | $140.55B |
Dividend Yield | 2.09% | 5.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About NatWest Group plc American Depositary Shares (each representing two (2) Ordinary Shares)
NatWest Group is a UK banking company serving personal, business, and institutional customers. Its services include deposits, lending, payments, and wealth management.
Read more on NWG →
